 PALO ALTO, Calif. and EDMONTON, Alberta, April 13, 2021 GLOBE NEWSWIRE -- BridgeBio Pharma, Inc. NASDAQ: BBIO and the Canadian Glycomics Network GlycoNet, a pan-Canadian Network of Centres of Excellence, today announced a collaboration to translate scientific research in glycomics into potential treatments for patients with genetic diseases. 